المؤلفون: Tan Y; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Xin L; Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China., Wang Q; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Xu R; Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China., Tong X; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Chen G; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Ma L; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Yang F; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Jiang H; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Zhang N; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Wu J; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Li X; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China., Guo X; Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China., Wang C; Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China., Zhou H; Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE) and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China. Electronic address: zhouhb@whu.edu.cn., Zhou F; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China. Electronic address: zhoufuling@whu.edu.cn.

المصدر: Cancer letters [Cancer Lett] 2024 Jun 28; Vol. 592, pp. 216933. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: fms-Like Tyrosine Kinase 3*/genetics , fms-Like Tyrosine Kinase 3*/antagonists & inhibitors , fms-Like Tyrosine Kinase 3*/metabolism , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Sulfonamides*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Xenograft Model Antitumor Assays* , Mutation*, Humans ; Animals ; Mice ; Cell Line, Tumor ; Pyrazines/pharmacology ; Drug Synergism ; Aniline Compounds/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Proteolysis/drug effects ; Female ; Protein Kinase Inhibitors/pharmacology

المؤلفون: van Weelderen RE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Harrison CJ; Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom., Klein K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., Jiang Y; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Salgrenska University Hospital, Gothenburg, Sweden., Alonzo T; Division of Biostatistics, University of Southern California, Los Angeles, CA., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Arad-Cohen N; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Bart-Delabesse E; Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'Hématologie secteur Génétique des Hémopathies, Toulouse, France., Buldini B; Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Department of Maternal and Child Health, Padua University, Padua, Italy., De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., Dworzak MN; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna & St. Anna Children's Cancer Research Institute, Vienna, Austria., Elitzur S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center & Tel Aviv University, Tel Aviv, Israel., Fernández Navarro JM; Department of Pediatric Oncohematology, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Gamis A; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Gerbing RB; Department of Statistics, Children's Oncology Group, Monrovia, CA., Goemans BF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; DCOG, Dutch Childhood Oncology Group, Utrecht, The Netherlands., Guest E; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Ha SY; Department of Pediatrics & Adolescent Medicine, Hong Kong Children's Hospital, Kowloon Bay, Hong Kong., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Kelaidi C; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Lapillonne H; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Leverger G; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Locatelli F; Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Polychronopoulou S; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Rasche M; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany., Rubnitz JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Stary J; Department of Pediatric Hematology and Oncology, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic., Tierens A; Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto General Hospital, Toronto, ON, Canada., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

المصدر: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3200-3213.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Myeloid-Lymphoid Leukemia Protein*/genetics , Histone-Lysine N-Methyltransferase*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/mortality, Humans ; Child ; Male ; Female ; Child, Preschool ; Adolescent ; Infant ; Prognosis ; Chromosome Aberrations ; Gene Rearrangement ; Retrospective Studies

المؤلفون: Ren Z; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Vanhooren J; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Derpoorter C; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., De Moerloose B; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Lammens T; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.

المصدر: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3299-3310.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: RNA, Long Noncoding*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/mortality , Leukemia, Myeloid, Acute*/diagnosis, Humans ; Child ; Prognosis ; Male ; Female ; Nucleophosmin ; Child, Preschool ; Recurrence ; Biomarkers, Tumor/genetics ; Transcriptome ; Adolescent ; Gene Expression Profiling ; Infant

المؤلفون: Salustiano-Bandeira ML; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Moreira-Aguiar A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Weinhäuser I; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., França-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima AS; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima AS; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Baccarin AR; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Silva FB; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., de Melo MA; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Niemann FS; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil., Nardinelli L; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil., Ortiz Rojas CA; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil., Duarte BK; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil., Araujo AS; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil., Azevedo EA; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil., Morais CN; Department of Virology, Fundação Oswaldo Cruz, Instituto de Pesquisas Aggeu Magalhães, Recife, Brazil., Figueiredo-Pontes LL; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Bendit I; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil., Rego EM; Hematology Division, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil., Olalla Saad ST; Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil.; Department of Internal Medicine, University of Campinas, Campinas, Brazil., Traina F; Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Bezerra MA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil. antonio.araujo@ufpe.br.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Jun 24; Vol. 14 (1), pp. 102. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/genetics , Tumor Protein p73*/genetics , Tumor Protein p73*/metabolism, Humans ; Prognosis ; Female ; Male ; Middle Aged ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism ; Aged ; Gene Expression Regulation, Leukemic ; Adult

المؤلفون: Liu Y; Institute of Biomedicine, Department of Cellular Biology, Jinan University, No. 601 Huangpu Ave West, Shipai Street, Tianhe District, Guangzhou, Guangdong, 510632, China., Zhu XY; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China., Liao LL; Research Center of Medical and Pharmaceutical Bioengineering, Minstry of Health, Guangdong Province Nucleic Acid Molecular Diagnostics Engineering Technology Research Center, Daan Gene Co Ltd, Guangzhou, 510663, China., Zhang ZH; Research Center of Medical and Pharmaceutical Bioengineering, Minstry of Health, Guangdong Province Nucleic Acid Molecular Diagnostics Engineering Technology Research Center, Daan Gene Co Ltd, Guangzhou, 510663, China., Huang TS; Research Center of Medical and Pharmaceutical Bioengineering, Minstry of Health, Guangdong Province Nucleic Acid Molecular Diagnostics Engineering Technology Research Center, Daan Gene Co Ltd, Guangzhou, 510663, China., Zhang L; Department of Hematology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Shipai Street, Tianhe District, Guangzhou, 510630, China. zhangl389@mail.sysu.edu.cn., Jiang XW; Research Center of Medical and Pharmaceutical Bioengineering, Minstry of Health, Guangdong Province Nucleic Acid Molecular Diagnostics Engineering Technology Research Center, Daan Gene Co Ltd, Guangzhou, 510663, China. xwjdaan@126.com., Ma Y; Institute of Biomedicine, Department of Cellular Biology, Jinan University, No. 601 Huangpu Ave West, Shipai Street, Tianhe District, Guangzhou, Guangdong, 510632, China. tmayi@jnu.edu.cn.; National engineering research center of genetic Medicine, Key laboratory of Bioengineering Medicine of Guangdong Province, Guangzhou, 510632, China. tmayi@jnu.edu.cn.; The National Demonstration Center for Experimental Education of Life Science and Technology, Jinan University, Guangzhou, 510632, China. tmayi@jnu.edu.cn.

المصدر: Biology direct [Biol Direct] 2024 Jun 24; Vol. 19 (1), pp. 49. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101258412 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6150 (Electronic) Linking ISSN: 17456150 NLM ISO Abbreviation: Biol Direct Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/drug therapy , HMGA2 Protein*/genetics , HMGA2 Protein*/metabolism , MicroRNAs*/genetics , MicroRNAs*/metabolism , Drug Resistance, Neoplasm*/genetics , Doxorubicin*/pharmacology , RNA, Long Noncoding*/genetics , RNA, Long Noncoding*/metabolism, Humans ; Mice ; Animals ; Cell Line, Tumor ; HL-60 Cells ; Gene Silencing ; Apoptosis ; Cell Proliferation ; Female

المؤلفون: Iaiza A; Department of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, P.le Aldo Moro, 5, 00185, Rome, Italy., Mazzanti G; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy., Goeman F; SAFU, Department of Research, Diagnosis and Innovative Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Cesaro B; Department of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, P.le Aldo Moro, 5, 00185, Rome, Italy., Cortile C; Department of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, P.le Aldo Moro, 5, 00185, Rome, Italy.; SAFU, Department of Research, Diagnosis and Innovative Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Corleone G; SAFU, Department of Research, Diagnosis and Innovative Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Tito C; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy., Liccardo F; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy., De Angelis L; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy., Petrozza V; Department of Medico-Surgical Science and Biotechnologies, Sapienza University of Rome, Latina, Italy., Masciarelli S; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy., Blandino G; Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy., Fanciulli M; SAFU, Department of Research, Diagnosis and Innovative Technologies, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Fatica A; Department of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, P.le Aldo Moro, 5, 00185, Rome, Italy. alessandro.fatica@uniroma1.it., Fontemaggi G; Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. giulia.fontemaggi@ifo.it., Fazi F; Section of Histology and Medical Embryology, Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Via A. Scarpa, 14-16, 00161, Rome, Italy. francesco.fazi@uniroma1.it.

المصدر: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Jun 23; Vol. 81 (1), pp. 276. Date of Electronic Publication: 2024 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: RNA, Circular*/genetics , RNA, Circular*/metabolism , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/drug therapy , Adenosine*/analogs & derivatives , Adenosine*/metabolism , Adenosine*/pharmacology , Oxidative Stress*/drug effects, Humans ; Bortezomib/pharmacology ; Cell Line, Tumor ; Reactive Oxygen Species/metabolism ; RNA Splicing Factors/metabolism ; RNA Splicing Factors/genetics ; Cell Cycle Proteins/metabolism ; Cell Cycle Proteins/genetics ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/pathology ; Heme Oxygenase-1/metabolism ; Heme Oxygenase-1/genetics ; Protein Serine-Threonine Kinases ; Intracellular Signaling Peptides and Proteins

المؤلفون: Ren J; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Huang J; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Yang Z; Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China., Sun M; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Yang J; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Lin C; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Jin F; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Liu Y; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Tang L; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Hu J; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Wei X; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Chen X; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Yuan Z; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China., Yang Z; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Chen Y; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. yanmengchen@cqmu.edu.cn., Zhang L; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. lingzhang@cqmu.edu.cn.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jun 22; Vol. 43 (1), pp. 176. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , TNF-Related Apoptosis-Inducing Ligand*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use , Apoptosis*/drug effects , Sulfonamides*/pharmacology , Sulfonamides*/therapeutic use , Drug Synergism*, Humans ; Animals ; Mice ; Cell Line, Tumor ; Nucleophosmin ; Xenograft Model Antitumor Assays ; Cytoplasm/metabolism ; Female ; Nuclear Proteins

المؤلفون: Saeed RH; Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq., Abdulrahman ZFA; Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq., Mohammad DK; College of Agricultural Engineering Sciences, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq. dara.mohammad@su.edu.krd.; Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, 141 83, Stockholm, Sweden. dara.mohammad@su.edu.krd.

المصدر: Scientific reports [Sci Rep] 2024 Jun 20; Vol. 14 (1), pp. 14251. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/blood , COVID-19*/genetics , COVID-19*/blood , COVID-19*/virology , MicroRNAs*/blood , MicroRNAs*/genetics, Humans ; Male ; Female ; Middle Aged ; Adult ; Cross-Sectional Studies ; Aged ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; SARS-CoV-2/isolation & purification ; Antigens, CD/genetics ; Antigens, CD/blood ; Antigens, CD/metabolism

المؤلفون: Sauter C; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France. camille.sauter@u-bourgogne.fr., Morin T; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Guidez F; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Simonet J; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Fournier C; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France., Row C; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France.; Department of Hematology Biology, University Hospital Dijon Bourgogne François-Mitterrand, Dijon, France., Masnikov D; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Pernon B; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Largeot A; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Tumor Stroma Interactions, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Aznague A; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Inserm UMS 58 BioSanD, CRISPR Functional Genomics (CRIGEN) facility, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Hérault Y; Université de Strasbourg, CNRS UMR7104, Inserm U1258, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch-Graffenstaden, France., Sauvageau G; Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada., Maynadié M; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Department of Hematology Biology, University Hospital Dijon Bourgogne François-Mitterrand, Dijon, France., Callanan M; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France.; Inserm UMS 58 BioSanD, CRISPR Functional Genomics (CRIGEN) facility, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Bastie JN; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Department of Clinical Hematology, University Hospital Dijon Bourgogne François-Mitterrand, Dijon, France., Aucagne R; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France.; Inserm UMS 58 BioSanD, CRISPR Functional Genomics (CRIGEN) facility, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France., Delva L; Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France. laurent.delva@u-bourgogne.fr.

المصدر: Communications biology [Commun Biol] 2024 Jun 20; Vol. 7 (1), pp. 753. Date of Electronic Publication: 2024 Jun 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Protein-Arginine N-Methyltransferases*/metabolism , Protein-Arginine N-Methyltransferases*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/pathology , Signal Transduction* , Inflammation*/metabolism , Inflammation*/genetics , Mice, Knockout* , NF-kappa B*/metabolism, Animals ; Humans ; Mice ; Cell Line, Tumor ; STAT3 Transcription Factor/metabolism ; STAT3 Transcription Factor/genetics ; Female ; Male ; Mice, Inbred C57BL ; Intracellular Signaling Peptides and Proteins

المصدر: Blood [Blood] 2024 Jun 20; Vol. 143 (25), pp. 2676.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: fms-Like Tyrosine Kinase 3*/genetics , fms-Like Tyrosine Kinase 3*/antagonists & inhibitors , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Protein Kinase Inhibitors*/therapeutic use , Mutation*, Humans ; Veterans ; United States ; Male ; United States Department of Veterans Affairs